No evidence of autoimmunity to human OX
Autoimmunity
Influenza A virus nucleoprotein
Narcolepsy
OX1
OX2
Pandemrix vaccination
Journal
Journal of translational autoimmunity
ISSN: 2589-9090
Titre abrégé: J Transl Autoimmun
Pays: Netherlands
ID NLM: 101759413
Informations de publication
Date de publication:
2020
2020
Historique:
received:
12
08
2019
revised:
15
04
2020
accepted:
23
04
2020
entrez:
4
8
2020
pubmed:
4
8
2020
medline:
4
8
2020
Statut:
epublish
Résumé
Narcolepsy type 1, likely an immune-mediated disease, is characterized by excessive daytime sleepiness and cataplexy. The disease is strongly associated with human leukocyte antigen (HLA) DQB1∗06:02. A significant increase in the incidence of childhood and adolescent narcolepsy was observed after a vaccination campaign with AS03-adjuvanted Pandemrix influenza vaccine in Nordic and several other countries in 2010 and 2011. Previously, it has been suggested that a surface-exposed region of influenza A nucleoprotein, a structural component of the Pandemrix vaccine, shares amino acid residues with the first extracellular domain of the human OX
Identifiants
pubmed: 32743535
doi: 10.1016/j.jtauto.2020.100055
pii: S2589-9090(20)30022-8
pii: 100055
pmc: PMC7388359
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100055Informations de copyright
© 2020 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Nat Rev Neurol. 2014 Nov;10(11):616-7
pubmed: 25311588
Cell. 1999 Aug 6;98(3):365-76
pubmed: 10458611
PLoS One. 2011;6(6):e20823
pubmed: 21695145
Sleep. 2009 Aug;32(8):979-83
pubmed: 19725248
PLoS One. 2017 Dec 8;12(12):e0187305
pubmed: 29220370
Nat Rev Neurosci. 2014 Nov;15(11):719-31
pubmed: 25301357
Am J Hum Genet. 2001 Mar;68(3):686-99
pubmed: 11179016
Curr Neurol Neurosci Rep. 2018 Jun 1;18(7):43
pubmed: 29855798
Nature. 2018 Oct;562(7725):63-68
pubmed: 30232458
Sleep Med. 2017 Jun;34:71-83
pubmed: 28522102
PLoS One. 2012;7(3):e33723
pubmed: 22470463
Sleep. 2010 Jul;33(7):869-74
pubmed: 20614846
Sleep. 2002 Mar 15;25(2):197-202
pubmed: 11902429
Vaccine. 2012 Jan 17;30(4):745-51
pubmed: 22138177
J Clin Microbiol. 2011 May;49(5):2009-11
pubmed: 21367994
PLoS One. 2014 Sep 29;9(9):e108489
pubmed: 25264897
J Biol Chem. 1992 Dec 25;267(36):25898-907
pubmed: 1281477
J Clin Invest. 2010 Mar;120(3):713-9
pubmed: 20160349
Neuron. 2000 Sep;27(3):469-74
pubmed: 11055430
Sleep. 2017 Feb 01;40(2):
pubmed: 28364500
PLoS One. 2012;7(3):e33536
pubmed: 22470453
Ann Neurol. 2011 Sep;70(3):410-7
pubmed: 21866560
Vaccine. 2020 Feb 18;38(8):1933-1942
pubmed: 31987689
Sleep. 2006 Nov;29(11):1429-38
pubmed: 17162989
Euro Surveill. 2014 May 01;19(17):15-25
pubmed: 24821121
Autoimmunity. 2019 Jun;52(4):185-191
pubmed: 31328572
Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):322-7
pubmed: 9419374
Tissue Antigens. 2003 Aug;62(2):162-9
pubmed: 12889996
BMJ. 2013 Feb 26;346:f794
pubmed: 23444425
Lancet. 2000 Jan 1;355(9197):39-40
pubmed: 10615891
Neurology. 2001 Dec 11;57(11):2029-33
pubmed: 11739821
Neurology. 2013 Apr 2;80(14):1315-21
pubmed: 23486871
J Virol Methods. 2017 Apr;242:35-45
pubmed: 28025125
PLoS One. 2014 Dec 15;9(12):e114361
pubmed: 25501681
FEBS Lett. 2011 May 6;585(9):1368-74
pubmed: 21510948
Autoimmunity. 2016 Sep;49(6):421-433
pubmed: 27206786
Sleep. 2007 Jan;30(1):13-26
pubmed: 17310860
J Autoimmun. 2015 Sep;63:68-75
pubmed: 26227560
Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):E3735-44
pubmed: 25136085
J Neurosci. 2006 Oct 18;26(42):10658-66
pubmed: 17050705
PLoS One. 2013 Aug 08;8(8):e68402
pubmed: 23950869
Cancer Res. 1982 Sep;42(9):3858-63
pubmed: 6286115
Sleep. 2009 Dec;32(12):1548
pubmed: 20041589
Cell. 1999 Aug 20;98(4):437-51
pubmed: 10481909
Sleep Med. 2013 Sep;14(9):867-71
pubmed: 23773727
Sci Transl Med. 2015 Jul 1;7(294):294ra105
pubmed: 26136476
Lancet Neurol. 2014 Jun;13(6):600-13
pubmed: 24849861
Vaccine. 2011 Feb 17;29(9):1836-43
pubmed: 21199698